New MRI technique aims to help surgeons remove more of a deadly brain tumor
NCT ID NCT06455189
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This trial tests whether a new type of MRI, called MR fingerprinting, can better show where a glioblastoma (an aggressive brain tumor) has spread compared to standard MRI. The goal is to help surgeons remove more of the tumor safely. The study involves adults with suspected glioblastoma and will first check if the approach is safe and feasible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MR fingerprinting-guided surgical resection
What this could lead to
If successful, this approach could help surgeons remove more tumor tissue during glioblastoma surgery, potentially delaying recurrence.
What could go wrong
This is a small, early-phase safety and feasibility study. The new MRI technique may not improve outcomes or could increase surgical risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Cleveland Medical Center, UH Department of Radiology, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States